Source: Eur Respir J 2001; 18: 298-305
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Navarro J., Rainisio M., Harms H.K., Hodson M.E., Koch C., Mastella G., Strandvik B., McKenzie S.G.. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. Eur Respir J 2001; 18: 298-305

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002 CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 LATE-BREAKING ABSTRACT: Socio-economic status does not influence lung function decline in children with cystic fibrosis in Australia Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 Does the lung clearance index track with disease progression in early childhood? Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 Infant pulmonary function - Raised Volume Technique Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Emphysema distribution determines distinct pulmonary function features Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Underestimation of lung clearance index values in infants with cystic fibrosis due to software analysis algorithms Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects Year: 2015 Infant pulmonary function - Multiple Breath Washout Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Structural lung disease, pulmonary infection and inflammation in infancy is associated with reduced spirometry at school-age in children with cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 Ability of lung clearance index to track changes in a routine clinical CF setting Source: International Congress 2015 – Paediatric respiratory physiology Year: 2015 Benchmarking of pulmonary function studies in a large regional pulmonary function laboratory. Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns Source: International Congress 2015 – IPF: clinical aspects II Year: 2015